ArtVentive Medical has completed first human clinical study with its EOS Peripheral vascular occlusion device and has demonstrated 100% acute procedural and clinical success providing a predictable, immediate occlusion of all targeted blood vessels.
The EOS is a catheter based self-expandable device, used to achieve permanent or temporary (reversible) occlusion of blood vessels or other tubular structures in a human body.
The clinical study involved six male patients who were infertile and suffered pain in the low pelvic area and had conditions related to venous peripheral disease, known as varicocele.
The study was performed by George Washington University Medical Center Vascular and Interventional Radiology Division director Anthony Venbrux and Italian Clinic in Asuncion, Paraguay Adrian Ebner.
ArtVentive Medical Group president and CTO Rudakov said the performance of the device showed the advantage for occlusion of vessels in a wide spectrum of peripheral vascular applications.
ArtVentive Medical Group through its proprietary technology, has developed minimally invasive occlusion devices and procedures, bringing the interventional image guided techniques to resolve unaddressed health issues.